Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
59
CADL Quote, Financials, Valuation and Earnings
Last price:
$8.74
Seasonality move
:
-11.47%
Day range:
$8.25 - $10.00
52-week range:
$1.08 - $14.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2,118.19x
P/B ratio:
25.38x
Volume:
4.8M
Avg. volume:
6.6M
1-year change:
681.25%
Market cap:
$284.2M
Revenue:
--
EPS (TTM):
-$1.73
Earnings Data
Next earnings date for CADL
Mar 28
2025
Most recent earnings per share
-$0.33
Missed by $0.33
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CADL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/28/2025 | Q4 | -- | -- | -- | -- | -- |
| 11/14/2024 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$0.74 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/28/2024 | Q4 | -- | -- | -$0.38 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$0.29 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.33 | -$0.37 | $0.04 |
| 05/11/2023 | Q1 | -- | -- | -$0.30 | -$0.35 | $0.05 |
| 03/30/2023 | Q4 | -- | -- | -$0.18 | -$0.39 | $0.21 |
| 11/10/2022 | Q3 | -- | -- | -$0.30 | -$0.36 | $0.06 |
| 08/05/2022 | Q2 | -- | -- | -$0.14 | -$0.44 | $0.30 |
| 05/12/2022 | Q1 | -- | -- | -$0.03 | -$0.31 | $0.28 |
| 03/29/2022 | Q4 | -- | -- | $0.06 | -- | -- |
| 11/12/2021 | Q3 | -- | -- | -$0.69 | -- | -- |
| 09/08/2021 | Q2 | -- | -- | -$0.69 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.24 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.56 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.14 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.15 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.09 | -- | -- |
Candel Therapeutics Earnings Questions
-
How Much did Candel Therapeutics Generate in Revenue Last Quarter?
Candel Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Candel Therapeutics Beat Earnings Last Quarter?
Candel Therapeutics announced earnings per share of -$0.33 which represents a miss of analyst forecast a -- per share.
-
Is Candel Therapeutics Profitable?
Candel Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Candel Therapeutics EPS Next Year?
Candel Therapeutics's earnings are forecast to decrease from -$1.31 per share to -$1.05 per share next year representing a decrease of -19.9%.
-
When is Candel Therapeutics's Earnings Date?
Candel Therapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
